この記事を読む

TP53変異とエルロチニブ+ラムシルマブ

RELAY, Ramucirumab Plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association Between…

この記事を読む

MET発現とPD-L1とドライバー変異

Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matc…

この記事を読む

高齢者SCLCに対するCBDCA+CPT-11

Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung c…

この記事を読む

周術期の化学療法+ペムブロリズマブ、生存延長を証明できるか?

Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer. Wakelee H et al.N Engl J Med. 2023 Jun 3. Epub a…

この記事を読む

免疫チェックポイント阻害薬投与直後のソトラシブで肝機能異常重篤化

Severe sotorasib-related hepatotoxicity and non-liver adverse events associated with sequential anti-PD(L)1 and sotorasi…

この記事を読む

ⅠB~ⅢA期への術後オシメルチニブの生存期間延長効果

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC. Tsuboi M et al.N Engl J Med. 2023 Jun4. Epub ahead of …

この記事を読む

非喫煙者にもCT検診が有効?

Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting L…

この記事を読む

局所進行胸腺腫の不完全切除例をどうするか

Unradical Surgery for Locally-Advanced Thymoma: Is it time to evolve Perspectives? Mastromarino MG et al.Lung Cancer. Ep…

この記事を読む

血漿T790Mをモニターし、オシメルチニブへ切り替える戦略は有効か?

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC):E…

この記事を読む

オンコマインかAMOYか、不一致例は何が原因か

Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Kunimasa KLung Cancer. 2023 May;179:107190.PMID: …